Similar articles

• Ribavirin: a role in HIV infection?

  Bodsworth N, Cooper DA. Bodsworth N, et al. J Acquir Immune Defic Syndr (1988). 1990;3(9):893-5. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2384865 No abstract available.
• A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.

  Roberts RB, Hollinger FB, Parks WP, Rasheed S, Laurence J, Heseltine PN, Makuch RW, Lubina JA, Johnson KM. Roberts RB, et al. AIDS. 1990 Jan;4(1):67-72. doi: 10.1097/00002030-199001000-00009. AIDS. 1990. PMID: 1690551 Clinical Trial.
• Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men.

  Schulof RS, Parenti DM, Simon GL, Paxton H, Meyer WA 3rd, Schlesselman SB, Courtless J, LeLacheur S, Sztein MB. Schulof RS, et al. J Acquir Immune Defic Syndr (1988). 1990;3(5):485-92. J Acquir Immune Defic Syndr (1988). 1990. PMID: 1691287 Clinical Trial.
• In re ribavirin: a case of premature adjudication?

  Wald ER, Dashefsky B, Green M. Wald ER, et al. J Pediatr. 1988 Jan;112(1):154-8. doi: 10.1016/s0022-3476(88)80143-4. J Pediatr. 1988. PMID: 3275765 Review. No abstract available.
• What is the clinical role of aerosolized ribavirin?

  Hebert MF, Guglielmo BJ. Hebert MF, et al. DICP. 1990 Jul-Aug;24(7-8):735-8. doi: 10.1177/106002809002400717. DICP. 1990. PMID: 2197815 Review.